Profound Medical (PROF) Enterprise Value (2019 - 2026)

Profound Medical has reported Enterprise Value for 8 years, with the latest figure at $204.7 million in Q2 2026.

• On a quarterly basis, Enterprise Value rose 44.01% year-over-year to $204.7 million in Q2 2026; TTM through Jun 2026 was $204.7 million, a 44.01% increase from a year earlier, with the FY2025 full-year figure at $178.2 million, up 35.96% from the prior year.
• Enterprise Value was $204.7 million for Q2 2026 at Profound Medical, up from $185.2 million in the prior quarter.
• The five-year high for Enterprise Value was $207.2 million in Q1 2024, with the low at $122.8 million in Q3 2025.
• Average Enterprise Value over 5 years is $169.7 million, with a median of $179.5 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Enterprise Value tumbled 38.01% in 2025, then soared 44.13% in 2026.
• Over 5 years, Enterprise Value stood at $180.9 million in 2022, then fell by 14.18% to $155.2 million in 2023, then dropped by 15.56% to $131.1 million in 2024, then jumped by 35.96% to $178.2 million in 2025, then advanced by 14.85% to $204.7 million in 2026.
• The last three Enterprise Value figures came in at $204.7 million (Q2 2026), $185.2 million (Q1 2026), and $178.2 million (Q4 2025), per Business Quant data.